GLUC - Glucose Health, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
568.62k
Enterprise Value 3
998.06k
Trailing P/E
N/A
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
6.45
Price/Book (mrq)
N/A
Enterprise Value/Revenue 3
11.32
Enterprise Value/EBITDA 6
N/A

Trading Information

Stock Price History

Beta (3Y Monthly) 0.99
52-Week Change 322.05%
S&P500 52-Week Change 310.73%
52 Week High 30.2075
52 Week Low 30.0711
50-Day Moving Average 30.1469
200-Day Moving Average 30.1596

Share Statistics

Avg Vol (3 month) 311.4k
Avg Vol (10 day) 34.75k
Shares Outstanding 54.55M
Float 3.86M
% Held by Insiders 110.50%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 250/1
Last Split Date 3Nov 17, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Sep 30, 2017

Profitability

Profit Margin -96.52%
Operating Margin (ttm)-36.82%

Management Effectiveness

Return on Assets (ttm)-57.69%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)88.13k
Revenue Per Share (ttm)0.02
Quarterly Revenue Growth (yoy)1,027.20%
Gross Profit (ttm)19.17k
EBITDA N/A
Net Income Avi to Common (ttm)-85.06k
Diluted EPS (ttm)-0.0230
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)16.64k
Total Cash Per Share (mrq)0
Total Debt (mrq)332.88k
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.06
Book Value Per Share (mrq)-0.12

Cash Flow Statement

Operating Cash Flow (ttm)-17.25k
Levered Free Cash Flow (ttm)-77.44k